UnknownNot Applicable

INTER-PATHOLOGIST READER STUDY

United States500 participantsStarted 2023-06-15

Plain-language summary

This is a post study histology analysis from previously obtained pathology slides.

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Histology scans must have been obtained from previous consented subjects that allows post study ad hoc analyses.
✓. Histology scans must be available from the data collected from the Orlucent OMS002, SFI001 or SFI003 Studies and are of good quality.

Study Success

Timeframe: 8 months

NCT IDNCT06246903

SponsorOrlucent, Inc

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-06-20